Pancreatic Cancer Research

ResearcherJikei University School of MedicineNo recent work listed

Mikio Kajihara

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3316-1121; OpenAlex author ID A5039762495. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2014: 2 papers · 2015: 2 papers · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper

Papers 9

  1. Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1. Co-author DOI 10.1159/000500359↗
  2. Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2018.8961↗
  3. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2017.6071↗
  4. Comprehensive assessment of the prognosis of pancreatic cancer: peripheral blood neutrophil-lymphocyte ratio and immunohistochemical analyses of the tumour sit… Co-author DOI 10.3109/00365521.2015.1121515↗
  5. Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer. Co-author DOI 10.3748/wjg.v22.i18.4446↗
  6. Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft Model. Co-author DOI 10.1371/journal.pone.0142981↗
  7. Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for p… Co-author PMID 25550602↗
  8. Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-14-0314↗
  9. Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing haemodialysis. Co-author DOI 10.1179/1973947813y.0000000150↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shigeo Koido · 8 shared papers, 2014–2019 · strength 0.41
  2. Zensho Ito · 6 shared papers, 2015–2019 · strength 0.34
  3. Kazuki Takakura · 7 shared papers, 2014–2018 · strength 0.33
  4. Masato Okamoto · 5 shared papers, 2014–2019 · strength 0.26
  5. Haruo Sugiyama · 4 shared papers, 2014–2019 · strength 0.21
  6. Tomoya Kanai · 3 shared papers, 2016–2018 · strength 0.18
  7. Shigetaka Shimodaira · 3 shared papers, 2014–2019 · strength 0.17
  8. Shin Kan · 3 shared papers, 2014–2019 · strength 0.15
  9. Masayuki Saruta · 2 shared papers, 2018–2019 · strength 0.15
  10. Toshifumi Ohkusa · 2 shared papers, 2017–2019 · strength 0.14
  11. Shuichi Fujioka · 2 shared papers, 2017–2018 · strength 0.13
  12. Sadamu Homma · 3 shared papers, 2014–2015 · strength 0.12
  13. Hisao Tajiri · 3 shared papers, 2014–2015 · strength 0.11
  14. Sayumi Yoshida · 1 shared paper, 2019 · strength 0.08
  15. Sumiyuki Nishida · 1 shared paper, 2018 · strength 0.07
  16. Shintaro Tsukinaga · 2 shared papers, 2014 · strength 0.07
  17. Koichiro Haruki · 1 shared paper, 2016 · strength 0.05
  18. Takeshi Gocho · 1 shared paper, 2016 · strength 0.05
  19. Yuki Fujiwara · 1 shared paper, 2016 · strength 0.05
  20. Akitaka Takahara · 1 shared paper, 2014 · strength 0.04
  21. Yoichi Toyama · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.